✦ LIBER ✦

PMH20 A COST-BENEFIT ANALYSIS OF HIGHER MEDICATION COPAYMENTS IN VETERANS WITH SCHIZOPHRENIA

✍ Scribed by JE Zeber; LA Copeland; M Valenstein; AL Miller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH20 TREATMENT PATHWAYS AND COST ASSESS

✍ E Aggelopoulos; M Geitona; K Zaharakis; P Kakavas; V Karpouza; S Kesidou; C Kous 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PMH48 VALIDATING A COST-EFFECTIVENESS AN

✍ C Graham; J Mauskopf; AH Lawson; H Ascher-Svanum; D Bruhn; PR Watson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH30 COST-EFFECTIVENESS ANALYSIS IN THE

✍ S Crowley; R Schrover; AM Neville 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Poster #247 LONGITUDINAL MEDICATION ADHE

✍ Zeber, John E.; Stock, Eileen M.; Pugh, Mary Jo V.; Tsan, Jack Y.; Pugh, Jacquel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Cost-Benefit Analysis of Scrotal Ultraso

✍ Walker, Adam R.; Kogan, Barry A. 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 138 KB

PCV20 The Association of Antihypertensiv

✍ C. Park; S. Jang; S. Jang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB